PETS PetMed Express, Inc. - Common Stock
NASDAQ · Retail · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026PETS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
PETS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About PetMed Express, Inc. - Common Stock Company overview from Wikipedia
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PETS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05Y avg ≈9.3 | ≈9.3 | · | · | |
| P/S (TTM) | 0.25Y avg ≈0.3 | ≈0.3 | 0.2 | Fair value | |
| P/B (MRQ) | 1.35Y avg ≈1.2 | ≈1.2 | · | · | |
| Price / FCF (TTM) | -1.15Y avg ≈-247.6 | ≈-247.6 | · | · | |
| Price / Cash Flow (TTM) | -1.25Y avg ≈13.4 | ≈13.4 | · | · | |
| Price / Tangible Book (MRQ) | 1.75Y avg ≈2.2 | ≈2.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PETS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 27.9%5Y avg ≈28.5% | ≈28.5% | 36.4% | Weak | |
| Operating Margin (TTM) | -18.2%5Y avg ≈-8.5% | ≈-8.5% | -1.3% | Weak | |
| EBITDA Margin (TTM) | -12.7%5Y avg ≈-5.8% | ≈-5.8% | -1.3% | Weak | |
| Pretax Margin (TTM) | -17.4%5Y avg ≈-7.9% | ≈-7.9% | -2.0% | Weak | |
| Net Profit Margin (TTM) | -17.3%5Y avg ≈-8.9% | ≈-8.9% | -2.0% | Weak | |
| ROA (TTM) | -33.7%5Y avg ≈-19.4% | ≈-19.4% | -13.0% | Weak | |
| ROE (TTM) | -78.6%5Y avg ≈-38.2% | ≈-38.2% | 12.9% | Weak | |
| ROIC | -202.5%5Y avg ≈-77.2% | ≈-77.2% | -31.5% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PETS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.75Y avg ≈1.1 | ≈1.1 | 1.3 | Low liquidity | |
| Quick Ratio | 0.45Y avg ≈0.7 | ≈0.7 | 0.3 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PETS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -21.1%5Y avg ≈-9.2% | ≈-9.2% | · | · | |
| Revenue CAGR 3Y | -10.2%5Y avg ≈-6.5% | ≈-6.5% | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PETS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.65Y avg ≈1.5 | ≈1.5 | 1.5 | In line | |
| Receivables Turnover | 84.75Y avg ≈92.6 | ≈92.6 | 84.7 | In line | |
| Revenue / Employee | ≈$947.2K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Aug 11, 2023 | $0.30 | USD | ≈9.4% |
| Jun 5, 2023 | $0.30 | USD | ≈8.2% |
| Feb 16, 2023 | $0.30 | USD | ≈6.1% |
| Nov 17, 2022 | $0.30 | USD | ≈6.3% |
| Aug 11, 2022 | $0.30 | USD | ≈5.4% |
| May 19, 2022 | $0.30 | USD | ≈5.9% |
| Feb 4, 2022 | $0.30 | USD | ≈5.0% |
| Nov 5, 2021 | $0.30 | USD | ≈3.8% |
| Aug 5, 2021 | $0.30 | USD | ≈4.0% |
| May 13, 2021 | $0.30 | USD | ≈4.1% |
| Jan 29, 2021 | $0.28 | USD | ≈2.9% |
| Nov 6, 2020 | $0.28 | USD | ≈3.7% |
| Jul 30, 2020 | $0.28 | USD | ≈3.5% |
| May 14, 2020 | $0.28 | USD | ≈3.4% |
| Jan 31, 2020 | $0.27 | USD | ≈4.3% |
| Nov 1, 2019 | $0.27 | USD | ≈4.7% |
| Aug 1, 2019 | $0.27 | USD | ≈6.7% |
| May 16, 2019 | $0.27 | USD | ≈5.5% |
| Feb 1, 2019 | $0.27 | USD | ≈4.6% |
| Nov 2, 2018 | $0.27 | USD | ≈3.7% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2027 | Aug 13, 2026 | $-0.28 | $0.12 | -328.8% |
| Dec. 31, 2026 | Jun 2, 2026 | $-0.19 | $-0.18 | -3.5% |
| June 30, 2026 | Aug 13, 2026 | $-0.28 | $0.12 | -328.8% |
| March 31, 2026 | $-0.19 | $-0.18 | -3.5% | |
| Dec. 31, 2025 | $-0.50 | $-0.06 | -717.0% | |
| June 30, 2025 | $-1.65 | $-0.07 | -2210.9% | |
| March 31, 2025 | $-0.56 | $-0.05 | -1129.2% | |
| Dec. 31, 2024 | $-0.03 | $-0.01 | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | $4.12 | $4.57 | · | $6.78 | $6.97 | $6.45 | $6.51 | $5.62 | · | · | · | |
| Revenue / Share | $8.56 | $11.02 | $13.78 | $12.62 | $13.43 | $15.37 | · | · | $13.40 | · | · | · | |
| Cash Flow / Share | $-1.36 | $0.23 | $0.21 | $1.37 | $0.91 | $1.99 | $1.94 | $2.20 | $1.83 | · | · | · | |
| Cash / Share | $1.00 | $2.65 | $2.61 | · | $5.29 | $5.86 | $5.15 | $4.86 | $3.78 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 | $0.85 | $0.76 | $0.72 | · | |
| EPS (TTM) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.80 |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Income Statement
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,597,807 | 20,513,281 | · | 20,425,282 | 20,382,979 | 20,332,526 | · | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,938,817 | 20,941,505 | · | 20,425,282 | 20,780,455 | 20,332,526 | · | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Balance Sheet
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Cash Flow
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Profitability
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Liquidity & Solvency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Efficiency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Per Share
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.06 | · | $1.53 | $2.05 | $2.47 | · | $4.66 | $4.67 | $4.54 | · | $4.73 | $4.75 | $4.92 | · | $6.34 | $6.55 | |
| Revenue / Share | $1.89 | · | $1.94 | $2.12 | $2.47 | · | $2.57 | $2.85 | $3.24 | · | $3.20 | $3.42 | $3.85 | · | $2.90 | $3.21 | |
| Cash Flow / Share | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.41 | · | · | · | $0.03 | · | · | · | |
| Cash / Share | $0.60 | · | $1.26 | $1.72 | $1.97 | · | $2.43 | $2.52 | $2.23 | · | $2.34 | $2.53 | $2.91 | · | $4.86 | $4.58 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | |
| EPS (TTM) | $-1.37 | · | $-3.12 | $-2.65 | $-2.13 | · | $0.02 | $-0.05 | $-0.13 | · | $-0.14 | $-0.05 | $0.06 | · | $0.44 | $0.66 |
Valuation (TTM)
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $169M | · | $187M | $198M | $212M | · | $236M | $247M | $259M | · | $262M | $256M | $250M | · | $253M | $256M | |
| Net Income TTM | $-29M | · | $-65M | $-55M | $-44M | · | $357.0K | $-963.0K | $-3M | · | $-3M | $-849.0K | $1M | · | $9M | $13M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -1.4 | · | -1.0 | -0.9 | -1.6 | · | 241.0 | -73.6 | -31.2 | · | -54.0 | -205.0 | 229.8 | · | 40.2 | 29.6 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.2 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| Dividend Yield | 0.05% | · | 0.04% | 0.05% | 0.11% | · | 0.19% | 0.27% | 7.8% | · | 11.8% | 11.5% | 8.5% | · | 6.6% | 5.9% | |
| Earnings Yield | -71.4% | · | -97.5% | -105.6% | -64.2% | · | 0.41% | -1.4% | -3.2% | · | -1.8% | -0.49% | 0.44% | · | 2.5% | 3.4% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · | |
| Annual Payout | $20.0K | · | $29.0K | $29.0K | $78.0K | · | $194.0K | $208.0K | $6M | · | $19M | $25M | $25M | · | $24M | $24M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | · |
| Gross Margin % | 28.1% | 30.5% | 28.0% | 27.6% | · |
| Operating Margin % | -32.8% | -0.67% | -2.9% | 2.4% | · |
| Net Income | $-57M | $-6M | $-7M | $5M | · |
| Diluted EPS | $-2.74 | $-0.30 | $-0.37 | $0.25 | · |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | · |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | · |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | · |
Institutional owners (13F) 53 filers · $11.9M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 10 (0 vs prior Q) | 8 (-2 vs prior Q) | 9 (-1 vs prior Q) | 18 (+2 vs prior Q) | -1.3M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3,084,028 | 963,759 | 26.00% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,171,962 | 1,131,230 | 18.31% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,588,602 | 827,397 | 13.39% | Shares |
| BlackRock, Inc. | $1,091,050 | 568,255 | 9.20% | Shares |
| FEDERATED HERMES, INC. | $407,367 | 212,170 | 3.43% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $391,947 | 204,075 | 3.30% | Shares |
| STEEL PARTNERS HOLDINGS L.P. | $371,835 | 193,664 | 3.13% | Shares |
| UBS Group AG | $265,594 | 138,330 | 2.24% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232,412 | 121,048 | 1.96% | Shares |
| Rangeley Capital, LLC | $232,320 | 121,000 | 1.96% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $212,124 | 110,481 | 1.79% | Shares |
| STATE STREET CORP | $201,932 | 105,173 | 1.70% | Shares |
| Formidable Asset Management, LLC | $195,056 | 85,551 | 1.64% | Shares |
| Empowered Funds, LLC | $158,108 | 82,348 | 1.33% | Shares |
| TUDOR INVESTMENT CORP ET AL | $156,301 | 81,407 | 1.32% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152,646 | 79,503 | 1.29% | Shares |
| CITADEL ADVISORS LLC | $142,324 | 74,127 | 1.20% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $115,811 | 60,353 | 0.98% | Shares |
| UMB Bank, n.a. | $115,200 | 60,000 | 0.97% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91,647 | 47,733 | 0.77% | Shares |
| NORTHERN TRUST CORP | $81,893 | 42,653 | 0.69% | Shares |
| XTX Topco Ltd | $80,511 | 41,933 | 0.68% | Shares |
| CIBC Private Wealth Group LLC | $75,300 | 30,000 | 0.63% | Shares |
| SIMPLEX TRADING, LLC | $47,702 | 24,845 | 0.40% | Shares |
| IMC-Chicago, LLC | $44,014 | 22,924 | 0.37% | Shares |
| TUDOR INVESTMENT CORP ET AL | $29,568 | 15,400 | 0.25% | Call option |
| Jain Global LLC | $26,148 | 13,619 | 0.22% | Shares |
| AMERICAN CENTURY COMPANIES INC | $24,712 | 12,871 | 0.21% | Shares |
| MORGAN STANLEY | $22,282 | 11,604 | 0.19% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $17,637 | 9,186 | 0.15% | Shares |
| Vanguard Global Advisers, LLC | $15,590 | 8,120 | 0.13% | Shares |
| OSAIC HOLDINGS, INC. | $6,772 | 3,527 | 0.06% | Shares |
| SBI Securities Co., Ltd. | $2,148 | 1,119 | 0.02% | Shares |
| Bank & Trust Co | $2,054 | 901 | 0.02% | Shares |
| HARBOUR INVESTMENTS, INC. | $1,037 | 540 | 0.01% | Shares |
| Accredited Wealth Management, LLC | $1,004 | 5,636 | 0.01% | Shares |
| Allworth Financial LP | $949 | 494 | 0.01% | Shares |
| MCF Advisors LLC | $768 | 400 | 0.01% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0.01% | Shares |
| Ascentis Independent Advisors | $683 | 356 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0.00% | Shares |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0.00% | Shares |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $290 | 151 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129,933 | 0.00% | Shares |
| FMR LLC | $115 | 60 | 0.00% | Shares |
| Elevated Capital Advisors, LLC | $96 | 50 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0.00% | Shares |
| CITIGROUP INC | $17 | 9 | 0.00% | Shares |
| CoreCap Advisors, LLC | $8 | 4 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 filings | June 29, 2026 | 12.07% | Amendment | Passive investment | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | Feb. 11, 2026 | 1.83% | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 29 insiders · 8 officers · 16 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jeffrey Allen Willard | CEO and President | Sept. 28, 2026 A | 250,000 | 0 | 0 | $0 |
| Leslie C.G. Campbell | Interim CEO and President | Aug. 11, 2026 A | 145,000 | 0 | 0 | $0 |
| Sandra Yvette Campos | CEO & President | April 30, 2025 S | 578,524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | Jan. 27, 2021 S | 337,800 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | June 26, 2026 A | 102,500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | Sept. 27, 2024 A | 250,000 | 0 | 0 | $0 |
| Christine Chambers | CFO | May 31, 2024 D | 65,146 | 0 | 0 | $0 |
| Bruce S Rosenbloom | Chief Financial Officer | July 30, 2021 A | 45,450 | 0 | 0 | $0 |
| Tamar Elkeles | Director | Sept. 17, 2026 A | 49,923 | 0 | 0 | $0 |
| Peter Batushansky | Director | Aug. 11, 2026 A | 91,928 | 0 | 0 | $0 |
| Justin L. Mennen | Director | Aug. 11, 2026 A | 98,274 | 0 | 0 | $0 |
| Gian Fulgoni | Director | Jan. 21, 2026 D | 132,299 | 0 | 0 | $0 |
| Leah Solivan | Director | Oct. 30, 2025 A | 42,289 | 0 | 0 | $0 |
| Diana G Purcel | Director | Aug. 8, 2024 A | 24,375 | 0 | 0 | $0 |
| Jodi Watson | Director | July 28, 2022 A | 18,880 | 0 | 0 | $0 |
| Peter Cobb | Director | July 28, 2022 A | 15,000 | 0 | 0 | $0 |
| Ronald J Korn | Director | July 30, 2021 A | 90,833 | 0 | 0 | $0 |
| Frank J Formica | Director | Jan. 29, 2021 S | 55,000 | 0 | 0 | $0 |
| Robert C Schweitzer | Director | Aug. 28, 2020 S | 95,834 | 0 | 0 | $0 |
| Marc Puleo MD | Director | Aug. 16, 2005 J | 913,286 | 0 | 0 | $0 |
| SilverCape Investments Limited | 10% owner | Aug. 13, 2025 P | 2,579,696 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | 10% owner | Aug. 4, 2006 S | 2,284,000 | 0 | 0 | $0 |
| James Lacamp | · | Aug. 11, 2026 A | 90,421 | 0 | 0 | $0 |
| Jacqueline Paula Smith | · | Jan. 15, 2025 A | 28,099 | 0 | 0 | $0 |
| Mathew N Hulett | · | April 29, 2024 D | 103,850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | · | Dec. 11, 2023 A | 42,000 | 0 | 0 | $0 |
| Daniel Job Pingree | · | May 17, 2023 A | 22,000 | 0 | 0 | $0 |
| CRESLIN LTD | · | Aug. 4, 2006 S | 2,284,000 | 0 | 0 | $0 |
| Guven Kivilcim | · | Jan. 22, 2004 S | 1,310,300 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 20 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EWUS · iShares Trust | 0.25% | 37,222 SH | Sept. 11, 2026 | Daily |
| ISVL · iShares Trust | 0.17% | 202,554 SH | Sept. 11, 2026 | Daily |
| ISCF · iShares Trust | 0.09% | 216,018 SH | Sept. 11, 2026 | Daily |
| IEUS · iShares Trust | 0.07% | 45,419 SH | Sept. 11, 2026 | Daily |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.05% | 58,613 SH | Oct. 1, 2026 | Daily |
| SCZ · iShares Trust | 0.03% | 1,496,647 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 1,566,925 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 26,193 SH | Sept. 11, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 1,056,528 SH | Aug. 19, 2026 | Daily |
| IEUR · iShares Trust | 0.01% | 291,699 SH | Sept. 11, 2026 | Daily |
| IWC · iShares Trust | 0.01% | 51,213 SH | Sept. 11, 2026 | Daily |
| IEFA · iShares Trust | 0.00% | 3,372,753 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.00% | 546,389 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 684,652 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 211,088 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 602,795 SH | Aug. 19, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 6,557,275 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 341,189 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 4,366,658 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 78,854 SH | Aug. 19, 2026 | Daily |
PETS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-10-01Mean target $1.40 +2.9%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.